Skip to main content

Table 1 Clinical characteristics of asthma patients at stable disease and during loss of control

From: Ex vivo innate responses to particulate matter from livestock farms in asthma patients and healthy individuals

  Stable Loss of control P-value
ACQ 6.30 ± 1.04 20.60 ± 0.88 < 0.0001
WURSS 41.10 ± 8.97 60.10 ± 10.48 0.04
FEV1% predicted 103.0 ± 3.70 90.30 ± 5.89 0.01
FeNO (ppb) 39.40 ± 13.33 61.70 ± 15.40 0.24
Sputum eosinophils (%) 2.58 ± 1.45 13.46 ± 4.62 0.03
Sputum neutrophils (%) 41.90 ± 12.20 44.56 ± 8.30 0.65
Blood eosinophils (%) 3.39 ± 0.85 6.33 ± 2.15 0.07
Blood eosinophils (109/L) 0.22 ± 0.06 0.43 ± 0.17 0.13
Blood neutrophils (%) 55.19 ± 3.58 52.86 ± 3.23 0.19
Blood neutrophils (109/L) 3.80 ± 0.72 3.34 ± 0.32 0.35
  1. Data (mean ± SEM) for the 10 asthma patients of whom PBMCs were used. Data for all patients included in the corticosteroid interruption study is provided elsewhere [9,10,11]. ACQ, Asthma Control Questionnaire; WURSS, Wisconsin Upper Respiratory Symptom Survey; FEV1, forced expiratory volume in 1 second; FeNO, fraction exhaled nitric oxide